Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Ameliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain Injury.

Du X, West MB, Cheng W, Ewert DL, Li W, Saunders D, Towner RA, Floyd RA, Kopke RD.

Oxid Med Cell Longev. 2016;2016:4159357. doi: 10.1155/2016/4159357. Epub 2015 Dec 16.

2.

A multicenter study of the early detection of synaptic dysfunction in Mild Cognitive Impairment using Magnetoencephalography-derived functional connectivity.

Maestú F, Peña JM, Garcés P, González S, Bajo R, Bagic A, Cuesta P, Funke M, Mäkelä JP, Menasalvas E, Nakamura A, Parkkonen L, López ME, Del Pozo F, Sudre G, Zamrini E, Pekkonen E, Henson RN, Becker JT; Magnetoencephalography International Consortium of Alzheimer's Disease..

Neuroimage Clin. 2015 Aug 1;9:103-9. doi: 10.1016/j.nicl.2015.07.011. eCollection 2015.

3.

Protein Kinase C-Related Kinase (PKN/PRK). Potential Key-Role for PKN1 in Protection of Hypoxic Neurons.

Thauerer B, Zur Nedden S, Baier-Bitterlich G.

Curr Neuropharmacol. 2014 May;12(3):213-8. doi: 10.2174/1570159X11666131225000518.

4.

The Differences between Blast-Induced and Sports-Related Brain Injuries.

Chen Y, Huang W, Constantini S.

Front Neurol. 2013 Aug 14;4:119. doi: 10.3389/fneur.2013.00119. eCollection 2013. No abstract available.

5.

Global analysis of phosphorylation of tau by the checkpoint kinases Chk1 and Chk2 in vitro.

Mendoza J, Sekiya M, Taniguchi T, Iijima KM, Wang R, Ando K.

J Proteome Res. 2013 Jun 7;12(6):2654-65. doi: 10.1021/pr400008f. Epub 2013 Apr 26.

6.

Inorganic lead (Pb)- and mercury (Hg)-induced neuronal cell death involves cytoskeletal reorganization.

Choi WS, Kim SJ, Kim JS.

Lab Anim Res. 2011 Sep;27(3):219-25. doi: 10.5625/lar.2011.27.3.219. Epub 2011 Sep 30.

7.

A proteomic approach for comprehensively screening substrates of protein kinases such as Rho-kinase.

Amano M, Tsumura Y, Taki K, Harada H, Mori K, Nishioka T, Kato K, Suzuki T, Nishioka Y, Iwamatsu A, Kaibuchi K.

PLoS One. 2010 Jan 14;5(1):e8704. doi: 10.1371/journal.pone.0008704.

8.

Development of an intracellularly acting inhibitory peptide selective for PKN.

Shiga K, Takayama K, Futaki S, Hutti JE, Cantley LC, Ueki K, Ono Y, Mukai H.

Biochem J. 2009 Dec 23;425(2):445-53. doi: 10.1042/BJ20090380.

9.

Protein SUMOylation in neuropathological conditions.

Anderson DB, Wilkinson KA, Henley JM.

Drug News Perspect. 2009 Jun;22(5):255-65. doi: 10.1358/dnp.2009.22.5.1378636. Review.

10.

Genome-wide analysis to predict protein sequence variations that change phosphorylation sites or their corresponding kinases.

Ryu GM, Song P, Kim KW, Oh KS, Park KJ, Kim JH.

Nucleic Acids Res. 2009 Mar;37(4):1297-307. doi: 10.1093/nar/gkn1008. Epub 2009 Jan 12.

11.
12.

Supplemental Content

Support Center